Literature DB >> 2149649

Static and dynamic pupillometry for determination of the course of gradual detoxification of opiate-addicted patients.

J Grünberger1, L Linzmayer, G Fodor, O Presslich, M Praitner, N Loimer.   

Abstract

In order to assess the course of methadone (Heptadone) substitution therapy, 29 inpatients at the Vienna Psychiatric University Clinic (21 males, mean age = 27 years, SD 4 years; 8 females, mean age 29.75 years, SD 5.28 years) who were addicted to opium tea or to a mixture of opium and heroin were investigated by means of computer-assisted "static"- and "light-evoked dynamic" pupillometry. Pupillary measurements were carried out before the start of withdrawal, on the 2nd day 48 h after the administration of 10 mg methadone, and again after the maximum and half of the maximum dose of methadone had been administered. The constricted pupils (the effect of opiate) showed dilatation after the withdrawal syndrome appeared, but immediately after the start of the detoxification treatment, as well as 1 day after administration of the maximum methadone dose a decrease of pupillary diameter was observed. The narrowing of the pupil was followed by an increase in pupillary diameter, which peaked 48 h after the last minimal dose of methadone and nearly reached the normal level. The widening of the pupil reflects an increase of noradrenergic activity under conditions of opiate withdrawal. An increase of spontaneous fluctuations was observed during withdrawal and was only inhibited by the maximum dose of methadone. Finally, pupillary dynamics (shortening of latency time and increase of relative changes) improved during therapy. The pupillary measurement corresponded with clinical observations as well as with self-evaluation during treatment. Thus pupillometry seems to be a useful instrument for assessment of treatment of opiate-addicted patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2149649     DOI: 10.1007/bf02189980

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  8 in total

1.  Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine.

Authors:  G K Aghajanian
Journal:  Nature       Date:  1978-11-09       Impact factor: 49.962

2.  [Computer-assisted static and dynamic pupillometry for the characterization of tricyclic antidepressive agent, cianopramine].

Authors:  J Grünberger; L Linzmayer; S Gasic; B Saletu
Journal:  Arzneimittelforschung       Date:  1988-03

3.  [Pupillometry in psychopharmacologic experiments].

Authors:  J Grünberger; L Linzmayer; H Cepko; B Saletu
Journal:  Arzneimittelforschung       Date:  1986

4.  [Clinical psychodiagnosis using psychophysiologic procedures].

Authors:  J Grünberger; L Linzmayer; B Saletu
Journal:  Wien Med Wochenschr       Date:  1984-01-31

Review 5.  [Use of a microcomputer for routine studies and research in the field of clinical psychodiagnosis].

Authors:  J Grünberger; L Linzmayer; B Saletu; H Stöhr
Journal:  Biomed Tech (Berl)       Date:  1984-11       Impact factor: 1.411

6.  [Dynamic light-evoked pupillometry for the differentiation of psychotropic substances].

Authors:  J Grünberger; L Linzmayer; H Cepko; B Saletu
Journal:  Arzneimittelforschung       Date:  1987-03

7.  [Computer-assisted static and light-evoked dynamic pupillometry in psychosomatic patients].

Authors:  J Grünberger; L Linzmayer; P Gathmann; B Saletu
Journal:  Wien Klin Wochenschr       Date:  1985-10-25       Impact factor: 1.704

8.  [Factor analytic study and determination of rehabilitation of static and dynamic pupillometry in normal persons and psychopathologic groups].

Authors:  J Grünberger; L Linzmayer; R Wittek; B Saletu
Journal:  Wien Med Wochenschr       Date:  1987-04-30
  8 in total
  6 in total

1.  Agonist-antagonist combinations in opioid dependence: a translational approach.

Authors:  P Mannelli
Journal:  Dipend Patologiche       Date:  2010

Review 2.  Tolerance and withdrawal from prolonged opioid use in critically ill children.

Authors:  Kanwaljeet J S Anand; Douglas F Willson; John Berger; Rick Harrison; Kathleen L Meert; Jerry Zimmerman; Joseph Carcillo; Christopher J L Newth; Parthak Prodhan; J Michael Dean; Carol Nicholson
Journal:  Pediatrics       Date:  2010-04-19       Impact factor: 7.124

3.  Test-retest repeatability of the pupil light response to blue and red light stimuli in normal human eyes using a novel pupillometer.

Authors:  Kristina Herbst; Birgit Sander; Dan Milea; Henrik Lund-Andersen; Aki Kawasaki
Journal:  Front Neurol       Date:  2011-02-22       Impact factor: 4.003

4.  The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation.

Authors:  Gail D'Onofrio; Kathryn F Hawk; Andrew A Herring; Jeanmarie Perrone; Ethan Cowan; Ryan P McCormack; James Dziura; R Andrew Taylor; Edouard Coupet; E Jennifer Edelman; Michael V Pantalon; Patricia H Owens; Shara H Martel; Patrick G O'Connor; Paul Van Veldhuisen; Nicholas DeVogel; Kristen Huntley; Sean M Murphy; Michelle R Lofwall; Sharon L Walsh; David A Fiellin
Journal:  Contemp Clin Trials       Date:  2021-03-16       Impact factor: 2.261

5.  Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis-generating Small Clinical Studies.

Authors:  B T Gufford; G R Ainslie; J R White; M E Layton; J M Padowski; G M Pollack; M F Paine
Journal:  Clin Transl Sci       Date:  2017-05-23       Impact factor: 4.689

6.  A Pilot Study of Automated Pupillometry in the Treatment of Opioid Use Disorder.

Authors:  Crandall E Peeler; Merit Gorgy; Natalie Sadlak; Shaleen Sathe; Nina Tamashunas; Marissa G Fiorello; Howard Cabral; Michael K Paasche-Orlow; Zoe M Weinstein
Journal:  J Addict Med       Date:  2021 Nov-Dec 01       Impact factor: 3.702

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.